Chromadex Corp
Change company Symbol lookup
Select an option...
CDXC Chromadex Corp
PPIH Perma-Pipe International Holdings Inc
DPDW Deep Down Inc
WOLF Wolfspeed Inc
PAVM PAVmed Inc
CNBP Cornerstone Bancorp Inc
UPS United Parcel Service Inc
RHHBY Roche Holding AG
EGP Eastgroup Properties Inc
PMT PennyMac Mortgage Investment Trust
Go

Health Care : Life Sciences Tools & Services | Small Cap Growth
Company profile

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Closing Price
$1.75
Day's Change
0.05 (2.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.76
Day's Low
1.69
Volume
(Light)
Volume:
156,873

10-day average volume:
464,017
156,873
Annual Earnings Met Consensus (Year ending 12/2021)Next Earnings Announcement
Annual
Announced March 9, 2022
-$0.40Annual Estimate range
of 5 analysts
-$0.46 to -$0.402022 Earnings
will announce
(Unconfirmed) August 2, 2022

Annual Earnings History and Estimates

Show high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

CDXC's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.